{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:57:42Z","timestamp":1792202262400,"version":"4.4.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>CDKL5 Deficiency Disorder (CDD) is a rare, X-linked dominant condition that causes a developmental and epileptic encephalopathy (DEE). The incidence is between ~ 1:40,000 and 1:60,000 live births. Pathogenic variants in <jats:italic>CDKL5<\/jats:italic> lead to seizures from infancy and severe neurodevelopmental delay. During infancy and childhood, individuals with CDD suffer impairments affecting cognitive, motor, visual, sleep, gastrointestinal and other functions. Here we present the recommendations of international healthcare professionals, experienced in CDD management, to address the multisystem and holistic needs of these individuals. Using a Delphi method, an anonymous survey was administered electronically to an international and multidisciplinary panel of expert clinicians and researchers. To provide summary recommendations, consensus was set, <jats:italic>a priori<\/jats:italic>, as &amp;gt;70% agreement for responses. In the absence of large, population-based studies to provide definitive evidence for treatment, we propose recommendations for clinical management, influenced by this proposed threshold for consensus. We believe these recommendations will help standardize, guide and improve the medical care received by individuals with CDD.<\/jats:p>","DOI":"10.3389\/fneur.2022.874695","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:14:22Z","timestamp":1655709262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder"],"prefix":"10.3389","volume":"13","author":[{"given":"Sam","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Aledo-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bahi-Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus J.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Helen","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Demarest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia M.","family":"Pestana Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol-Anne","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Trivisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Zuberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim A.","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ejhg.2012.156","article-title":"The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy","volume":"21","author":"Fehr","year":"2013","journal-title":"Eur J Hum Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2019.02.015","article-title":"Cyclin-dependent kinase-like 5 deficiency disorder: clinical review","volume":"97","author":"Olson","year":"2019","journal-title":"Pediatr Neurol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-37101-8.00032-1","article-title":"Developmental encephalopathies","author":"Paciorkowski","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/jmg.2007.053504","article-title":"Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy","volume":"45","author":"Rosas-Vargas","year":"2008","journal-title":"J. Med. Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/NXG.0000000000000200","article-title":"Variants: improving our understanding of a rare neurologic disorder","volume":"3","author":"Hector","year":"2017","journal-title":"Neurol Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/375538","article-title":"Disruption of the serine\/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation","volume":"72","author":"Kalscheuer","year":"2003","journal-title":"Am J Hum Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/jhg.2010.143","article-title":"An isoform of the severe encephalopathy-related CDKL5 gene, including a novel exon with extremely high sequence conservation, is specifically expressed in brain","volume":"56","author":"Fichou","year":"2011","journal-title":"J. Hum. Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jmg.2004.026237","article-title":"CDKL5\/STK9 is mutated in Rett syndrome variant with infantile spasms","volume":"42","author":"Scala","year":"2005","journal-title":"J Med Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1006\/geno.1998.5391","article-title":"Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region","volume":"51","author":"Montini","year":"1998","journal-title":"Genomics."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1086\/426460","article-title":"Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5\/STK9) gene are associated with severe neurodevelopmental retardation","volume":"75","author":"Tao","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/426462","article-title":"Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation","volume":"75","author":"Weaving","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1375\/twin.13.2.168","article-title":"Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in rett syndrome and related disorders","volume":"13","author":"White","year":"2010","journal-title":"Twin Res Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0883073815599262","article-title":"Diagnostic Approach to genetic causes of early-onset epileptic encephalopathy","volume":"31","author":"G\u00fcrsoy","year":"2016","journal-title":"J Child Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/dmcn.12709","article-title":"Dravet syndrome in Sweden: a population-based study","volume":"57","author":"Rosander","year":"2015","journal-title":"Dev Med Child Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","article-title":"Incidence of dravet syndrome in a US population","volume":"136","author":"Wu","year":"2015","journal-title":"Pediatrics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1203\/PDR.0b013e3182242461","article-title":"Trends in the diagnosis of Rett syndrome in Australia","volume":"70","author":"Fehr","year":"2011","journal-title":"Pediatr Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1093\/brain\/awz195","article-title":"Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort","volume":"142","author":"Symonds","year":"2019","journal-title":"Brain."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1002\/ajmg.a.37851","article-title":"Functional abilities in children and adults with the CDKL5 disorder","volume":"170","author":"Fehr","year":"2016","journal-title":"Am J Med Genet A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-016-0418-y","article-title":"Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome","volume":"11","author":"Mangatt","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1111\/epi.16285","article-title":"CDKL5 deficiency disorder: relationship between genotype, epilepsy, cortical visual impairment, and development","volume":"60","author":"Demarest","year":"2019","journal-title":"Epilepsia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1177\/08830738211019284","article-title":"Cerebral visual impairment in CDKL5 deficiency disorder correlates with developmental achievement","volume":"36","author":"Brock","year":"2021","journal-title":"J Child Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1212\/WNL.0000000000003352","article-title":"Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder","volume":"87","author":"Fehr","year":"2016","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejpn.2015.09.001","article-title":"Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy","volume":"20","author":"M\u00fcller","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/cge.13862","article-title":"Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset","volume":"99","author":"MacKay","year":"2021","journal-title":"Clin Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing Rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr Open."},{"key":"B26","unstructured":""},{"key":"B27","unstructured":""},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00001888-197902000-00006","article-title":"Using Delphi to achieve congruent objectives and activities in a pediatrics department","volume":"54","author":"Loughlin","year":"1979","journal-title":"J Med Educ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2648.2006.03716.x","article-title":"Consulting the oracle: ten lessons from using the Delphi technique in nursing research","volume":"53","author":"Keeney","year":"2006","journal-title":"J Adv Nurs."},{"key":"B30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","article-title":"What are Delphi studies?","volume":"23","author":"Barrett","year":"2020","journal-title":"Evid Based Nurs."},{"key":"B31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.braindev.2009.02.004","article-title":"Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria","volume":"32","author":"Artuso","year":"2010","journal-title":"Brain Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jmg.2006.041467","article-title":"CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients","volume":"43","author":"Archer","year":"2006","journal-title":"J Med Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1093\/brain\/awn197","article-title":"Key clinical features to identify girls with CDKL5 mutations","volume":"131","author":"Bahi-Buisson","year":"2008","journal-title":"Brain."},{"key":"B34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.braindev.2019.05.003","article-title":"Phenotypic manifestations between male and female children with CDKL5 mutations","volume":"41","author":"Liang","year":"2019","journal-title":"Brain Dev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","article-title":"Mortality in Dravet syndrome","volume":"128","author":"Cooper","year":"2016","journal-title":"Epilepsy Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1016\/j.eplepsyres.2018.04.008","article-title":"Early mortality in SCN8A -related epilepsies","volume":"143","author":"Johannesen","year":"2018","journal-title":"Epilepsy Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1212\/WNL.0000000000007778","article-title":"SUDEP in the North American SUDEP Registry: the full spectrum of epilepsies","volume":"93","author":"Verducci","year":"2019","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1528-1167.2007.01520.x","article-title":"The three stages of epilepsy in patients with CDKL5 mutations","volume":"49","author":"Bahi-Buisson","year":"2008","journal-title":"Epilepsia."},{"key":"B39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1528-1167.2009.02308.x","article-title":"Xp223 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy","volume":"51","author":"Mei","year":"2010","journal-title":"Epilepsia."},{"key":"B40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1469-8749.2010.03889.x","article-title":"CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life","volume":"53","author":"Melani","year":"2011","journal-title":"Dev Med Child Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.410340613","article-title":"Electroclinical signs of benign neonatal familial convulsions","volume":"34","author":"Hirsch","year":"1993","journal-title":"Ann Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/j.1528-1167.2012.03656.x","article-title":"Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies","volume":"53","author":"Guerrini","year":"2012","journal-title":"Epilepsia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejmg.2014.11.007","article-title":"Molecular characterization of a cohort of 73 patients with infantile spasms syndrome","volume":"58","author":"Boutry-Kryza","year":"2015","journal-title":"Eur J Med Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1111\/epi.16923","article-title":"Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder","volume":"62","author":"Devinsky","year":"2021","journal-title":"Epilepsia."},{"key":"B45","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","article-title":"Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial","volume":"2","author":"O'Callaghan","year":"2018","journal-title":"Lancet Child Adolesc Health."},{"key":"B46","doi-asserted-by":"publisher","first-page":"107946","DOI":"10.1016\/j.yebeh.2021.107946","article-title":"Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: findings from a multicenter cohort","volume":"118","author":"Aledo-Serrano","year":"2021","journal-title":"Epilepsy Behav."},{"key":"B47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1528-1157.2003.05302.x","article-title":"Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome","volume":"44","author":"Leary","year":"2003","journal-title":"Epilepsia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/epi.13813","article-title":"Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: experience of >100 patients","volume":"58","author":"Lim","year":"2017","journal-title":"Epilepsia."},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ajmg.a.61012","article-title":"A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder","volume":"179","author":"Tangarorang","year":"2019","journal-title":"Am J Med Genet A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eplepsyres.2019.02.001","article-title":"Cannabis for refractory epilepsy in children: a review focusing on CDKL5 deficiency disorder","volume":"151","author":"Dale","year":"2019","journal-title":"Epilepsy Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2018.05.013","article-title":"Open-label use of highly purified CBD (Epidiolex\u00ae;) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes","volume":"86","author":"Devinsky","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2019.12.006","article-title":"Cannabis-based products for pediatric epilepsy: an updated systematic review","volume":"75","author":"Elliott","year":"2020","journal-title":"Seizure."},{"key":"B53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14581\/jer.17012","article-title":"Cannabinoids in the treatment of epilepsy: hard evidence at last?","volume":"7","author":"Perucca","year":"2017","journal-title":"J Epilepsy Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","article-title":"Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Knight","year":"2022","journal-title":"Lancet Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eplepsyres.2018.07.013","article-title":"Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 deficiency disorder","volume":"146","author":"Lim","year":"2018","journal-title":"Epilepsy Res."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3171\/2017.12.JNS172331","article-title":"Rates and predictors of seizure outcome after corpus callosotomy for drug-resistant epilepsy: a meta-analysis","author":"Chan","year":"2018","journal-title":"J Neurosurg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.3390\/ijms20205098","article-title":"Rett syndrome and CDKL5 deficiency disorder: from bench to clinic","volume":"20","author":"Kadam","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s10545-013-9590-6","article-title":"Poll-The BTS-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation","volume":"36","author":"Hagebeuk","year":"2013","journal-title":"J Inherit Metab Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/jsr.12512","article-title":"CDKL5 deficiency entails sleep apneas in mice","volume":"26","author":"Martire","year":"2017","journal-title":"J Sleep Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11136-009-9540-9","article-title":"Qualitative research and content validity: developing best practices based on science and experience","volume":"18","author":"Brod","year":"2009","journal-title":"Qual Life Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1177\/08830738211019576","article-title":"Content validation of clinician-reported items for a severity measure for CDKL5 deficiency disorder","volume":"36","author":"Saldaris","year":"2021","journal-title":"J Child Neurol."},{"key":"B62","unstructured":"Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044). Population and Quantitative Health Sciences Publications\n            BjornerJB\n            GandekB\n            ColeJ\n            KosinskiM"},{"key":"B63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00019053-200826050-00002","article-title":"Perspectives on patient-reported outcomes","volume":"26","author":"Leidy","year":"2008","journal-title":"Pharmacoeconomics."},{"key":"B64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10048-009-0177-1","article-title":"Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes","volume":"10","author":"Russo","year":"2009","journal-title":"Neurogenetics."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1866-1955-7-2","article-title":"There is variability in the attainment of developmental milestones in the CDKL5 disorder","volume":"7","author":"Fehr","year":"2015","journal-title":"J Neurodev Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/17518423.2019.1600066","article-title":"A systematic review investigating outcome measures and uptake barriers when children and youth with complex disabilities use eye gaze assistive technology","volume":"23","author":"Perfect","year":"2020","journal-title":"Dev Neurorehabil."},{"key":"B67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2017.01.032","article-title":"Scoliosis in Rett syndrome: progression, comorbidities, and predictors","volume":"70","author":"Killian","year":"2017","journal-title":"Pediatr Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"E607","DOI":"10.1097\/BRS.0b013e3181a95ca4","article-title":"Guidelines for management of scoliosis in Rett syndrome patients based on expert consensus and clinical evidence","volume":"34","author":"Downs","year":"2009","journal-title":"Spine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0146824","DOI":"10.1371\/journal.pone.0146824","article-title":"Clinical guidelines for management of bone health in rett syndrome based on expert consensus and available evidence","volume":"11","author":"Jefferson","year":"2016","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"103913","DOI":"10.1016\/j.ridd.2021.103913","article-title":"Eye-trackers, digital-libraries, and print-referencing: a single case study in CDKL5","volume":"112","author":"Benson-Goldberg","year":"2021","journal-title":"Res Dev Disabil."},{"key":"B71","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.25797","article-title":"Comparison of core features in four developmental encephalopathies in the rett natural history study","volume":"88","author":"Cutri-French","year":"2020","journal-title":"Ann Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/08830738211000179","article-title":"Gastrostomy tubes placed in children with neurologic impairment: associated morbidity and mortality","volume":"36","author":"Lin","year":"2021","journal-title":"J Child Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/archdischild-2018-315629","article-title":"Percutaneous endoscopic gastrostomy for refractory epilepsy and medication refusal","volume":"104","author":"Howard","year":"2019","journal-title":"Arch Dis Child."},{"key":"B74","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pediatrneurol.2004.09.006","article-title":"Ketogenic diet in pediatric epilepsy patients with gastrostomy feeding","volume":"32","author":"Hosain","year":"2005","journal-title":"Pediatr Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11689-021-09384-z","article-title":"Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder","volume":"13","author":"Olson","year":"2021","journal-title":"J Neurodev Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejpn.2017.04.1141","article-title":"Caregiver's perception of epilepsy treatment, quality of life and comorbidities in an international cohort of CDKL5 patients","volume":"21","author":"Amin","year":"2017","journal-title":"Hippokratia."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1038\/s41436-021-01300-z","article-title":"Correction to: Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2019.03.017","article-title":"Severity assessment in CDKL5 deficiency disorder","volume":"97","author":"Demarest","year":"2019","journal-title":"Pediatr Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/ajmg.a.33037","article-title":"Somatic mosaicism for a CDKL5 mutation as an epileptic encephalopathy in males","author":"Masliah-Plachon","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.braindev.2015.03.002","article-title":"Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing","volume":"37","author":"Kato","year":"2015","journal-title":"Brain Dev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1177\/0883073815573317","article-title":"Two siblings with a CDKL5 mutation: genotype and phenotype evaluation","volume":"30","author":"Hagebeuk","year":"2015","journal-title":"J Child Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ajmg.a.32806","article-title":"A CDKL5 mutated child with precocious puberty","author":"Saletti","year":"2009","journal-title":"Am J Med Genet A"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.874695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:14:26Z","timestamp":1655709266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.874695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":82,"alternative-id":["10.3389\/fneur.2022.874695"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.874695","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"article-number":"874695"}}